GSDMD and ischemic stroke: A study treating ischemic stroke with a monoclonal antibody targeting TNF- α found that the antibody favorably modulates microglial M1 / M2 polarization, rebalances Th 17 / Treg, cell dynamics, and suppresses Caspase-8-mediated GSDMD cleavage to prevent microglial pyroptosis.